Pediatrix Medical Group, Inc. (NYSE:MD – Get Free Report) was the recipient of a significant decline in short interest in March. As of March 31st, there was short interest totalling 1,860,000 shares, a decline of 35.6% from the March 15th total of 2,890,000 shares. Approximately 2.2% of the company’s stock are short sold. Based on an average daily volume of 660,000 shares, the short-interest ratio is presently 2.8 days.
Analyst Ratings Changes
MD has been the topic of a number of recent research reports. UBS Group upped their price objective on Pediatrix Medical Group from $16.50 to $18.50 and gave the stock a “neutral” rating in a research report on Friday, February 21st. StockNews.com upgraded Pediatrix Medical Group from a “hold” rating to a “buy” rating in a research note on Wednesday, January 22nd. Finally, Truist Financial reduced their target price on shares of Pediatrix Medical Group from $18.00 to $16.00 and set a “hold” rating on the stock in a report on Friday, April 11th. Four analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and an average target price of $16.75.
Check Out Our Latest Stock Analysis on MD
Institutional Investors Weigh In On Pediatrix Medical Group
Pediatrix Medical Group Stock Performance
Shares of MD stock traded down $0.29 during mid-day trading on Thursday, hitting $12.85. 483,614 shares of the stock were exchanged, compared to its average volume of 838,504. The stock’s fifty day simple moving average is $14.30 and its two-hundred day simple moving average is $13.94. The stock has a market capitalization of $1.10 billion, a price-to-earnings ratio of -10.71, a P/E/G ratio of 1.74 and a beta of 1.32. Pediatrix Medical Group has a 12-month low of $6.62 and a 12-month high of $17.67. The company has a debt-to-equity ratio of 0.81, a quick ratio of 1.42 and a current ratio of 1.60.
Pediatrix Medical Group (NYSE:MD – Get Free Report) last posted its quarterly earnings results on Thursday, February 20th. The company reported $0.49 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.37 by $0.12. The firm had revenue of $502.36 million during the quarter, compared to analysts’ expectations of $486.22 million. Pediatrix Medical Group had a negative net margin of 4.92% and a positive return on equity of 15.47%. On average, analysts forecast that Pediatrix Medical Group will post 1.38 EPS for the current year.
About Pediatrix Medical Group
Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.
See Also
- Five stocks we like better than Pediatrix Medical Group
- Business Services Stocks Investing
- Tariff Exemptions Set the Stage for a Taiwan Semiconductor Rally
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- Mitigating Tariffs: 3 Stocks to Gain From a Weaker U.S. Dollar
- Golden Cross Stocks: Pattern, Examples and Charts
- Broadcom’s Apple Relationship: AI Opportunity Meets Tariff Risk
Receive News & Ratings for Pediatrix Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pediatrix Medical Group and related companies with MarketBeat.com's FREE daily email newsletter.